Dmitry Klimchuk

Over 20 years in the pharmaceutical market of Russia and the CIS. Before founding his own company, he held senior roles in strategy, market research, market access and commercial functions at western pharmaceutical companies.

In 2013 he founded WIT Pharma, a market access consultancy for pharmaceutical manufacturers in Russia and the CIS. He personally leads market access and GR engagements: analytics and evidence packages supporting the review of a product's inclusion in state funding programs, health technology assessment and pharmacoeconomics. A particular focus is rare (orphan) diseases and EAEU regulation. Under his leadership the team has delivered 200+ projects for international and Russian companies.

Education: Sechenov University, the Institute of International Trade and Law, London Business School.